Trial
NCT00303888
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
National Cancer Institute (NCI)
Condition
Fallopian Tube Cancer
Intervention
docetaxel
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-17